江苏省乙型肝炎相关疾病住院患者直接医疗费用分析  

Direct Medical Cost of Hospitalized Patients With Hepatitis B Virus-related Diseases in Jiangsu Province

作　　者：余有任 张开金[1] 张华[1] 金辉[1] 杨永峰[2] 谢波[3] 包思敏 马永华[1] 刘桂圆 

机构地区：[1]东南大学公共卫生学院,江苏省南京市210009 [2]东南大学医学院附属第二医院肝病科 [3]东南大学医学院附属中大医院科教科

出　　处：《中国全科医学》2016年第22期2706-2709,共4页Chinese General Practice

基　　金：国家自然科学基金资助项目(81402769)

摘　　要：目的分析江苏省乙型肝炎(乙肝)相关疾病住院患者直接医疗费用,为进一步完善我国医疗保险(医保)政策提供依据。方法选取2014年1—12月江苏省某2所三级医院收治的乙肝相关疾病住院患者1 219例次,利用医院信息系统进行医疗记录的回顾性信息查询,重点调查患者的直接医疗费用以及个人临床信息。结果 1 219例次患者中,医保患者648例次(53.16%),缴费患者571例次(46.84%);接受抗病毒治疗患者480例次(39.38%),未接受抗病毒治疗患者739例次(60.62%)。乙肝相关疾病住院患者次均直接医疗费用为20 874.86元,其中药费13 478.90元(64.57%);医保患者和缴费患者的次均直接医疗费用分别为17 184.94、25 062.37元;接受抗病毒治疗患者和未接受抗病毒治疗患者的次均直接医疗费用分别为28 755.85、15 755.95元。结论乙肝相关疾病住院患者直接医疗费用中药费占较大比重;江苏省相关医疗保障政策仍需进一步完善;建议将抗病毒治疗作为乙肝治疗的首选方案。Objective To analyze the direct medical cost of hospitalized patients with hepatitis B virus（ HBV）-related diseases, and to provide basis for further improving health insurance system of China. Methods 1 219 hospitalized patients with HBV- related diseases, who received treatment in two tertiary hospitals in Jiangsu Province from January to December 2014,were enrolled in this study. We performed a retrospective information searching of medical records based on hospital information system, and emphasized the investigation of patients＇ direct medical expenses and individual clinical information. Results Among the 1 219 hospitalized patients,there were 648 cases（ 53. 16%） with medical insurance; 571cases（ 46. 84%） at their own expenses; 480 cases（ 39. 38%） received antiviral therapy,while 739 cases（ 60. 62%） did not receive antiviral therapy. Average direct medical cost of patients with HBV- related diseases was 20 874. 86 yuan,of which drug cost was 13 478. 90 yuan（ 64. 57%）; average direct medical costs of patients with insurance and patients at their own expenses were 17 184. 94 yuan and 25 062. 37 yuan respectively; average direct medical costs of antiviral therapy patients and non-antiviral patients were 28 755. 85 yuan and 15 755. 95 yuan respectively. Conclusion Medicine costs cover a significant proportion of direct medical expenses of hospitalized patients with HBV- related diseases; related medical security policy in Jiangsu Province needs to be further improved; antiviral therapy should be taken as the preferred alternative of HBV- related diseases treatment.

关 键 词：乙型肝炎 住院病人 费用 医疗 

分 类 号：R512.62[医药卫生—内科学]